After infection with R5-tropic HIV-1, the humanized mice with engrafted CCR5-NP treated PBMCs showed significantly higher levels of CD4+ T-cells and reduced viral loads compared with control mice engrafted with mock-treated PBMCs. The gene discussed is CCR5; the disease is infection.